Cite
HARVARD Citation
Gramatzki, D. et al. (2021). Telomerase reverse transcriptase promoter mutation– and O6-methylguanine DNA methyltransferase promoter methylation–mediated sensitivity to temozolomide in isocitrate dehydrogenase–wild-type glioblastoma: is there a link?. European journal of cancer. pp. 84-94. [Online].